RESUMO
Within the framework of orthosteric G protein coupled receptor (GPCR) polypharmacology herein we report the systematic elaboration and thorough evaluation of a data matrix generated by sampling the chemical space around a common 5,6-fused bicyclic heteroaromatic template applying characteristic pharmacophore elements of central nervous system (CNS) relevant aminergic GPCR ligands.
Assuntos
Indóis/química , Ligantes , Humanos , Indóis/metabolismo , Ligação Proteica , Receptores de Dopamina D2/química , Receptores de Dopamina D2/metabolismo , Receptores de Dopamina D3/química , Receptores de Dopamina D3/metabolismo , Receptores Acoplados a Proteínas G/química , Receptores Acoplados a Proteínas G/metabolismo , Receptores Histamínicos H3/química , Receptores Histamínicos H3/metabolismo , Receptores de Serotonina/química , Receptores de Serotonina/metabolismo , Relação Estrutura-AtividadeRESUMO
As a result of our exploratory programme aimed at elaborating dually acting compounds towards the serotonin (5-HT) transporter (SERT) and the 5-HT2C receptor a novel series of 3-amino-1-phenylpropoxy substituted diphenylureas was identified. From that collection two promising compounds (2 and 3) exhibiting highest 5-HT2C receptor affinity strongly inhibited the 5-HT2C receptor agonist 1-(3-chlorophenyl)piperazine (mCPP) induced hypomotility in mice. In further pursuance of that objective (2-aminoethyl)(benzyl)sulfamoyl diphenylureas and diphenylpiperazines have also been elaborated. Herein we report the synthesis of potent multiple-acting compounds from this new class. However, when two optimized representatives (6 and 14) possessing the desired in vitro profile were tested neither reduced the motor activity of mCPP treated animals. Comparative albeit limited in vitro structure-activity relationship (SAR) analysis and detailed in vivo studies are discussed and explanation for their intricate behaviour is proposed.
Assuntos
Ligantes , Receptor 5-HT2A de Serotonina/química , Receptor 5-HT2C de Serotonina/química , Proteínas da Membrana Plasmática de Transporte de Serotonina/química , Animais , Humanos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Camundongos , Permeabilidade/efeitos dos fármacos , Piperazinas/química , Piperazinas/farmacologia , Receptor 5-HT2A de Serotonina/metabolismo , Receptor 5-HT2C de Serotonina/metabolismo , Proteínas da Membrana Plasmática de Transporte de Serotonina/metabolismo , Agonistas do Receptor de Serotonina/química , Agonistas do Receptor de Serotonina/farmacologia , Relação Estrutura-AtividadeRESUMO
In order to identify molecular models of the human 5-HT6 receptor suitable for virtual screening, homology modeling and membrane-embedded molecular dynamics simulations were performed. Structural requirements for robust enrichment were assessed by an unbiased chemometric analysis of enrichments from retrospective virtual screening studies. The two main structural features affecting enrichment are the outward movement of the second extracellular loop and the formation of a hydrophobic cavity deep in the binding site. These features appear transiently in the trajectories and furthermore the stretches of uniformly high enrichment may only last 4-10 ps. The formation of the inner hydrophobic cavity was also linked to the active-like to inactive-like transition of the receptor, especially the so-called connector region. The best structural models provided significant and robust enrichment over three independent ligand sets.
Assuntos
Desenho de Fármacos , Receptores de Serotonina/metabolismo , Sítios de Ligação , Desenho Assistido por Computador , Humanos , Ligantes , Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Ligação Proteica , Conformação Proteica , Receptores de Serotonina/químicaRESUMO
The formation of ligand-protein complexes requires simultaneous adaptation of the binding partners. In structure based virtual screening, high throughput docking approaches typically consider the ligand flexibility, but the conformational freedom of the protein is usually taken into account in a limited way. The goal of this study is to elaborate a methodology for incorporating protein flexibility to improve the virtual screening enrichments on GPCRs. Explicit-solvated molecular dynamics simulations (MD) were carried out in lipid bilayers to generate an ensemble of protein conformations for the X-ray structures and homology models of both aminergic and peptidergic GPCRs including the chemokine CXCR4, dopamine D3, histamine H4, and serotonin 5HT6 holo receptor complexes. The quality of the receptor models was assessed by enrichment studies to compare X-ray structures, homology models, and snapshots from the MD trajectory. According to our results, selected frames from the MD trajectory can outperform X-ray structures and homology models in terms of enrichment factor and AUC values. Significant changes were observed considering EF1% values: comparing the original CXCR4, D3, and H4 targets and the additional 5HT6 initial models to that of the best MD frame resulted in 0 to 6.7, 0.32 to 3.5 (10×), 13.3 to 26.7 (2×), and 0 to 14.1 improvements, respectively. It is worth noting that rank-average based ensemble evaluation calculated for different ensemble sizes could not improve the results further. We propose here that MD simulation can capture protein conformations representing the key interacting points of the receptor but less biased toward one specific chemotype. These conformations are useful for the identification of a "consensus" binding site with improved performance in virtual screening.
Assuntos
Simulação de Acoplamento Molecular , Simulação de Dinâmica Molecular , Receptores CXCR4/química , Receptores de Dopamina D3/química , Receptores Acoplados a Proteínas G/química , Receptores Histamínicos/química , Receptores de Serotonina/química , Área Sob a Curva , Sítios de Ligação , Cristalografia por Raios X , Ensaios de Triagem em Larga Escala , Humanos , Ligantes , Bicamadas Lipídicas/química , Ligação Proteica , Estrutura Secundária de Proteína , Estrutura Terciária de Proteína , Receptores Histamínicos H4 , Homologia Estrutural de Proteína , Termodinâmica , Interface Usuário-ComputadorRESUMO
A new series of quinolinyl- and phenantridinyl-acetamides were synthesizer and evaluated against bradykinin B1 receptor. In vitro metabolic stability data were reported for the key compounds.The analgesic effect of compound 20 from the phenantridine series was proved in-vivo.
Assuntos
Acetamidas/síntese química , Antagonistas de Receptor B1 da Bradicinina , Fenantrenos/síntese química , Quinolinas/síntese química , Acetamidas/farmacologia , Analgésicos/síntese química , Analgésicos/farmacologia , Linhagem Celular , Humanos , Metabolismo , Fenantrenos/farmacologia , Quinolinas/farmacologiaRESUMO
Performance of Glide was evaluated in a sequential multiple ligand docking paradigm predicting the binding modes of 129 protein-ligand complexes crystallized with clusters of 2-6 cooperative ligands. Three sampling protocols (single precision-SP, extra precision-XP, and SP without scaling ligand atom radii-SP hard) combined with three different scoring functions (GlideScore, Emodel and Glide Energy) were tested. The effects of ligand number, docking order and druglikeness of ligands and closeness of the binding site were investigated. On average 36% of all structures were reproduced with RMSDs lower than 2 Å. Correctly docked structures reached 50% when docking druglike ligands into closed binding sites by the SP hard protocol. Cooperative binding to metabolic and transport proteins can dramatically alter pharmacokinetic parameters of drugs. Analyzing the cytochrome P450 subset the SP hard protocol with Emodel ranking reproduced two-thirds of the structures well. Multiple ligand binding is also exploited by the fragment linking approach in lead discovery settings. The HSP90 subset from real life fragment optimization programs revealed that Glide is able to reproduce the positions of multiple bound fragments if conserved water molecules are considered. These case studies assess the utility of Glide in sequential multiple docking applications.
Assuntos
Proteínas/metabolismo , Sítios de Ligação , LigantesRESUMO
A novel structure-based approach for site of metabolism prediction has been developed. This knowledge-based method consists of three steps: (1) generation of possible metabolites, (2) docking the predicted metabolites to the CYP binding site and (3) selection of the most probable metabolites based on their complementarity to the binding site. As a proof of concept we evaluated our method by using MetabolExpert for metabolite generation and Glide for docking into the binding site of the CYP2C9 crystal structure. Our method could identify the correct metabolite among the three best-ranked compounds in 69% of the cases. The predictive power of our knowledge-based method was compared to that achieved by substrate docking and two alternative literature approaches.
Assuntos
Hidrocarboneto de Aril Hidroxilases/química , Hidrocarboneto de Aril Hidroxilases/metabolismo , Bases de Conhecimento , Cânfora/química , Cânfora/metabolismo , Domínio Catalítico , Simulação por Computador , Citocromo P-450 CYP2C9 , Flurbiprofeno/análogos & derivados , Flurbiprofeno/química , Flurbiprofeno/metabolismo , Humanos , Modelos Moleculares , Conformação Proteica , Especificidade por SubstratoRESUMO
Thermodynamics of ligand binding is influenced by the interplay between enthalpy and entropy contributions of the binding event. The impact of these binding free energy components, however, is not limited to the primary target only. Here, we investigate the relationship between binding thermodynamics and selectivity profiles by combining publicly available data from broad off-target assay profiling and the corresponding thermodynamics measurements. Our analysis indicates that compounds binding their primary targets with higher entropy contributions tend to hit more off-targets compared with those ligands that demonstrated enthalpy-driven binding.
Assuntos
Preparações Farmacêuticas/química , Termodinâmica , Química Farmacêutica , Ligantes , Preparações Farmacêuticas/metabolismo , Ligação ProteicaRESUMO
In contrast to designed polypharmacology that can result in efficient drugs for complex disorders, unintended drug promiscuity has detrimental contribution to side effects and toxicology. Characterization of promiscuous compounds enhances the understanding of complex interaction patterns and aids the design of compounds with broader selectivity against off-targets that has a major impact on medicinal chemistry outcome. In this Miniperspective we provide insights to the effect of physicochemical parameters on promiscuity. Information collected from recent, large-scale in vitro studies enabled us to discuss the relationships between physicochemical properties and promiscuity in detail. In light of these data, lipophilicity and basic character have the highest influence. On the basis of the accumulated knowledge, we propose the extensive use of pre- and postsynthesis metrics, as well as strict control of physicochemical properties during medicinal chemistry optimizations.
Assuntos
Descoberta de Drogas , Fenômenos Químicos , Química Farmacêutica , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Humanos , Lipídeos/química , Peso Molecular , Preparações Farmacêuticas/metabolismo , Relação Estrutura-AtividadeRESUMO
Lipophilic efficiency indices such as LLE and LELP were suggested to support balanced optimization of potency and ADMET profile. Here we investigated the performance of LLE and LELP on multiple data sets representing different stages of drug discovery including fragment and HTS hits and leads, development candidates, phase II compounds, and launched drugs. Analyzing their impact on ADME and safety properties and binding thermodynamics, we found that both LLE and LELP help identifying better quality compounds. LLE is sensible for the development stages but does not prefer fragment-type hits, while LELP has an advantage for this class of compounds and discriminates preferred starting points effectively. Both LLE and LELP have significant impact on ADME and safety profiles; however, LELP outperforms LLE in risk assessment at least on the present data set. On the basis of the results reported here, monitoring lipophilic efficiency metrics could contribute significantly to compound quality and might improve the output of medicinal chemistry programs.
Assuntos
Preparações Farmacêuticas/química , Transporte Biológico Ativo , Fármacos do Sistema Nervoso Central/efeitos adversos , Fármacos do Sistema Nervoso Central/química , Fármacos do Sistema Nervoso Central/metabolismo , Físico-Química , Descoberta de Drogas , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos , Microssomos/metabolismo , Octanóis , Permeabilidade , Preparações Farmacêuticas/metabolismo , Ligação Proteica , Relação Estrutura-Atividade , Termodinâmica , ÁguaRESUMO
Due to their impact on pharmacokinetic and pharmacodynamic properties the accurate prediction of dissociation constants is of outmost importance in drug discovery settings. The prediction accuracy, however, is typically assessed on public datasets most likely included in the training sets of the available tools. In this work we therefore tested five pK(a) prediction softwares such as ACD, Epik, Marvin, PharmaAlgorithm and Pallas on novel, never-published compounds. Our dataset consists of 177 pK(a) values of 95 structurally diverse in-house compounds prepared for real-life drug discovery programs. The thorough analysis of prediction accuracy allowed us identifying the best practice and exploring the limitations of the current methods. Mean absolute errors (0.86-1.28) obtained for this set of discovery compounds indicates the potential in the improvement of the available pK(a) prediction approaches. Limitations were further characterized by measuring and evaluating 39 pK(a) values of additional 28 commercially available compounds representing the most challenging chemotypes. We believe that these results would facilitate further developments and hopefully contribute to the necessary improvement of the prediction accuracy.
Assuntos
Descoberta de Drogas , Cromatografia Líquida de Alta Pressão , Modelos Teóricos , Farmacocinética , Relação Quantitativa Estrutura-Atividade , Espectrofotometria UltravioletaRESUMO
INTRODUCTION: Preclinical research involves the in vitro monitoring of metabolic stability to deliver compounds with improved ADME profiles. Prediction of the metabolically vulnerable points can substantially help in analyzing CYP-mediated metabolism data and support optimization efforts in drug discovery programs. Moreover, fast and reliable in silico predictions could accelerate the characterization of in vitro/in vivo metabolites. AREAS COVERED: This paper reviews in silico methods available for CYP-mediated site of metabolism (SOM) prediction. Comprehensive and practical knowledge in this field can guide the identification of best practice and may inspire ideas for the development of novel approaches. EXPERT OPINION: Comparison of the efficacy of SOM prediction methodologies revealed the general dependency on the studied isoform and substrate set. Increasing knowledge on P450 X-ray structures, on biotransformations and on the mechanistic details of the catalytic cycle revolutionized the prediction of SOM. Although no ultimate solution exits, combined methods covering both steric and electronic effects are preferred on most of the pharmaceutically relevant isoforms.
Assuntos
Biotransformação , Biologia Computacional/métodos , Sistema Enzimático do Citocromo P-450/química , Sistema Enzimático do Citocromo P-450/metabolismo , Preparações Farmacêuticas/química , Preparações Farmacêuticas/metabolismo , Sistema Enzimático do Citocromo P-450/genética , HumanosRESUMO
BACKGROUND: Due to its impact on multidrug resistance and pharmacokinetics P-glycoprotein (P-gp) has been identified as an important anti-target in pharmaceutical research. Recent publication of the mouse P-gp structure prompted us to build a new model for human P-gp and investigate its binding-site characteristics. RESULTS: We developed and validated the human P-gp model that was used for induced-fit docking of experimentally characterized P-gp substrates. Residues located in the binding pocket are in good correlation with the results of side-directed mutagenesis studies. However, enrichment studies aimed at discriminating inhibitors and substrates from decoys resulted in only limited enrichments. CONCLUSION: A mouse P-gp-based homology model might be useful when analyzing protein-ligand interactions of known human P-gp substrates if induced-fit effects are considered.
Assuntos
Membro 1 da Subfamília B de Cassetes de Ligação de ATP , Sítios de Ligação , Modelos Moleculares , Preparações Farmacêuticas/metabolismo , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/química , Membro 1 da Subfamília B de Cassetes de Ligação de ATP/metabolismo , Animais , Resistência a Múltiplos Medicamentos , Humanos , Camundongos , Ligação ProteicaRESUMO
Genetic evidences indicate that alkaline/neutral invertases are present in plant cell organelles, and they might have a novel physiological function in mitochondria. The present study demonstrates an invertase activity in the mitochondrial matrix of Helianthus tuberosus tubers. The pH optimum, the kinetic parameters and the inhibitor profile of the invertase activity indicated that it belongs to the neutral invertases. In accordance with this topology, transport activities responsible for the mediation of influx/efflux of substrate/products were studied in the inner mitochondrial membrane. The transport of sucrose, glucose and fructose was shown to be bidirectional, saturable and independent of the mitochondrial respiration and membrane potential. Sucrose transport was insensitive to the inhibitors of the proton-sucrose symporters. The different kinetic parameters and inhibitors as well as the absence of cross-inhibition suggest that sucrose, glucose and fructose transport are mediated by separate transporters in the inner mitochondrial membrane. The mitochondrial invertase system composed by an enzyme activity in the matrix and the corresponding sugar transporters might have a role in both osmoregulation and intermediary metabolism.